EGFR and non-small cell lung carcinoma: An oncogene-centric molecular classification paradigm in non-small cell lung cancer (NSCLC) has been established by the discoveries of mutual-exclusive oncogenic drivers, e.g., KRAS, EGFR, BRAF, and ALK1.